CN111529598A - 一种养元补气中药组合物及其制备方法 - Google Patents
一种养元补气中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN111529598A CN111529598A CN202010604406.6A CN202010604406A CN111529598A CN 111529598 A CN111529598 A CN 111529598A CN 202010604406 A CN202010604406 A CN 202010604406A CN 111529598 A CN111529598 A CN 111529598A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- parts
- tonifying
- fruit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 121
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 58
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 25
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 21
- 241000005787 Cistanche Species 0.000 claims abstract description 19
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 19
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 19
- 239000000284 extract Substances 0.000 claims abstract description 19
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 238000000926 separation method Methods 0.000 claims abstract description 10
- 239000009636 Huang Qi Substances 0.000 claims abstract description 9
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 8
- 229940107666 astragalus root Drugs 0.000 claims abstract description 7
- 238000012216 screening Methods 0.000 claims abstract description 6
- 239000008187 granular material Substances 0.000 claims description 12
- 235000006533 astragalus Nutrition 0.000 claims description 11
- 230000002829 reductive effect Effects 0.000 claims description 11
- 241001061264 Astragalus Species 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 210000004233 talus Anatomy 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 210000003734 kidney Anatomy 0.000 abstract description 34
- 230000000694 effects Effects 0.000 abstract description 25
- 230000006870 function Effects 0.000 abstract description 6
- 230000032683 aging Effects 0.000 abstract description 5
- 239000013589 supplement Substances 0.000 abstract description 4
- 230000036737 immune function Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 230000007812 deficiency Effects 0.000 description 20
- 208000024891 symptom Diseases 0.000 description 14
- 235000017784 Mespilus germanica Nutrition 0.000 description 7
- 244000182216 Mimusops elengi Species 0.000 description 7
- 235000000560 Mimusops elengi Nutrition 0.000 description 7
- 235000007837 Vangueria infausta Nutrition 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 241000336291 Cistanche deserticola Species 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 206010041497 Spermatorrhoea Diseases 0.000 description 4
- 208000031975 Yang Deficiency Diseases 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 241000045403 Astragalus propinquus Species 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241001632052 Haloxylon ammodendron Species 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 102000009151 Luteinizing Hormone Human genes 0.000 description 2
- 108010073521 Luteinizing Hormone Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- 208000017971 listlessness Diseases 0.000 description 2
- 229940040129 luteinizing hormone Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 2
- 235000021259 spicy food Nutrition 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000336315 Cistanche salsa Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 241001002545 Engelhardia roxburghiana Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 241000736078 Schisandra sphenanthera Species 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000010370 hearing loss Effects 0.000 description 1
- 231100000888 hearing loss Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 239000003688 hormone derivative Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种养元补气中药组合物,包括以下重量份数的组份:黄芪1‑50份、女贞子1‑50份、五味子1‑50份、肉苁蓉1‑50份和枸杞子1‑50份。本发明还提供所述养元补气中药组合物的制备方法,包括以下步骤:S1、将黄芪、女贞子、五味子、肉苁蓉和枸杞子混合粉碎,经筛分后获得中药粉末;S2、将中药粉末放置于水中煎煮后固液分离,获得中药提取液;S3、将中药提取液进行浓缩,得到中药浸膏;S4、将中药浸膏进行制剂,获得养元补气中药组合物。该中药组合物能为人体补气养元,添精益肾,同时还起到抗衰老,提高人体免疫功能的作用,解决了市场中的补肾药物会对人体产生毒副作用,见效慢和疗效不显著的问题。
Description
技术领域
本发明涉及中药组合物制备技术领域,尤其涉及一种养元补气中药组合物及其制备方法。
背景技术
肾虚是指肾脏精气阴阳不足。肾虚的种类有很多,其中最常见的是肾阴虚和肾阳虚。肾阳虚的症状为“寒”,主要有腰酸、四肢发冷、畏寒,甚至还有水肿等症状;肾阴虚的症状为“热”,主要有腰酸、燥热、盗汗、虚汗、头晕、耳鸣等症状。中医认为,肾虚多为长期积累成疾,其病因主要包括:不良好的生活习惯;长期受忧郁、恐惧等不良情绪影响;饮食不当,营养单一,经常食用油腻食物或辛辣食物,吸烟饮酒过度等。
如果男性肾虚,且不及时、正确地补足,可能引发多种并发症状。诸如:“肾虚”会引发慢性支气管炎、肺气肿和高血压。并且,冠心病、糖尿病、慢性肾炎等也与“肾虚”有关。女性肾虚的危害也不可忽视,如果得不到及时的补足,它会使更年期提前,会让女性眼睑浮肿,黑眼圈加重,面色苍白,甚至血压上升。此外,无论肾阴虚还是肾阳虚,都会导致人的免疫能力的降低。
目前,市场中存在诸多补肾药物,包括西药和中成药。其中,西药虽然见效较快,但含有大量合成激素,服用后会产生药物依赖。中成药虽然副作用小,但是也存在较明显的不足之处,例如只能用于治疗单一病因引起的肾虚,不能辩证施治多种病因引起的肾虚以及疗效慢、疗效不显著等。因此,为治疗肾虚疾病,寻求一种养元补气中药组合物及其制备方法已成为本领域技术人员要解决的新课题。
发明内容
本发明的目的在于提供一种养元补气中药组合物及其制备方法,能为人体补气养元,添精益肾,同时还起到抗衰老,提高人体免疫功能的作用,解决市场中的补肾药物会对人体产生毒副作用,见效慢和疗效不显著的问题。
本发明提供一种养元补气中药组合物,包括以下重量份数的组份:
黄芪1-50份、女贞子1-50份、五味子1-50份、肉苁蓉1-50份和枸杞子1-50份。
黄芪,味甘性温,归肺、脾经,可以作为补气药。黄芪能益气固表,可治疗脾气虚弱、倦怠乏力;黄芪可以敛汗固脱,黄芪能够补肺脾之气,可固表止汗,能治疗脾肺气虚所致的卫气不固、表虚自汗。黄芪不但能够升阳举陷,也能够治疗脾虚、中气下陷所致的久泻脱肛、内脏下垂等疾病;黄芪也能利尿消肿治标。在本发明中,黄芪最为重要的作用的是为人体补气养元。
女贞子为木犀科植物女贞的果实。根据《本草经疏》记载,“女贞子,气味俱阴,正入肾除热补精之要品,肾得补,则五脏自安,精神自足,百病去而身肥健矣”。女贞子能滋肾益肝,可用于治疗肝肾阴虚、精血不能上承导致的须发早白或视物昏暗等病症,能够乌发明目。
五味子为木兰科植物五味子或华中五味子的干燥成熟果实,其果含有五味子素及维生素C、树脂、鞣质及少量糖类。五味子可以养阴固精,能促进性事持久及增进女性外阴的刺激感受性。它能激活一氧化氮(NO)的产生,进而增强男性的体力和持久力。五味子还能够延缓衰老,五味子所含的木酚素是强效抗氧化剂,能抑制自由基,并能增加肝脏内的抗氧化剂-谷胱甘肽的水平。并且,木酚素还能增强腺嘌呤核苷三磷酸(ATP)或粒线体(细胞能量库)的能量生产,同时保护粒线体免受氧化压力所侵害。此外,五味子还能增强体能,提高人体免疫力。
肉苁蓉是一种寄生在沙漠树木梭梭根部的寄生植物,从梭梭寄主中吸取养分及水分。肉苁蓉具有补肾阳,益精血,润肠道的功效,且能治疗精血不足、阳痿、遗精等症。另外,肉苁蓉有一定程度的抗衰老作用。因为肉苁蓉可使小鼠红细胞超氧化物歧化酶(SOD)的活性明显增强,使小鼠心肌脂褐质含量明显降低。肉苁蓉具有调整内分泌、促进代谢及强壮身体的作用。肉苁蓉能够调整阳虚和阴虚动物的肝脾核酸含量,有激活肾上腺、释放皮质激素的作用,其作用机制是增强下丘脑-垂体-卵巢促黄体功能,提高垂体对促黄体释放激素(LRH)的反应性及卵巢对促***(LH)的反应性。肉苁蓉含有一种激活核苷酸还原酶的生物活性因子,该生物活性因子能显著地提高“阳虚”动物DNA合成率。
枸杞子,为茄科植物枸杞的成熟果实。枸杞子富含枸杞多糖,枸杞多糖是一种水溶性多糖,由***糖、葡萄糖、半乳糖、甘露糖、木糖、鼠李糖等单糖成分组成,具有生理活性,能够增强非特异性免疫功能,提高抗病能力,抑制肿瘤生长和细胞突变。免疫衰老与细胞凋亡密切相关。枸杞多糖能明显提高吞噬细胞的吞噬功能,提高淋巴细胞的增殖能力。所以,枸杞子具有抗衰老的作用。据《本草纲目》记载,“枸杞子甘平而润,性滋补……能补肾、润肺、生精、益气,此乃平补之药”。因此,枸杞子还具有益气、补肾和生精的作用。
在本发明中,1-50份的黄芪和1-50份的枸杞子相搭配,能增强组合物养元补气的功效。1-50份的女贞子、1-50份五味子和1-50份肉苁蓉组合在一起,能够巩固并强化各自的添精益肾作用。五味子具有延缓衰老的功效,肉苁蓉能够补强五味子的抗衰老作用,辅之以女贞子,能乌发明目。此外,1-50份的枸杞子和1-50份的五味子搭配,能有效提升该中药组合物增强人体免疫力的效果。
进一步,所述养元补气中药组合物,包括以下重量份数的组份:
黄芪10-30份、女贞子15-35份、五味子5-30份、肉苁蓉20-40份和枸杞子10-30份。
为了实现中药组分更加科学、合理搭配,强化中药组合物添精益肾、养元补气的功效,本发明对组分的用量做出上述改进。
本发明还提供所述养元补气中药组合物的制备方法,包括以下步骤:
S1、将黄芪、女贞子、五味子、肉苁蓉和枸杞子混合粉碎,经筛分后获得中药粉末;
S2、将中药粉末放置于水中煎煮后固液分离,获得中药提取液;
S3、将中药提取液进行浓缩,得到中药浸膏;
S4、将中药浸膏进行制剂,获得养元补气中药组合物。
将黄芪、女贞子、五味子、肉苁蓉和枸杞子混合粉碎,利于后续的煎煮。经过煎煮,中药粉末中的药物成分将溶于水中。经过固液分离,可获得溶有药物成分的中药提取液。对中药提取液进行浓缩,可收集到有效的中药成分,方便制剂。
进一步,所述步骤S1具体包括:
将黄芪、女贞子、五味子、肉苁蓉和枸杞子混合后粉碎,经50-100目筛筛分后获得中药粉末。
经50-100目筛筛分后获得的中药粉末,在煎煮时,中药粉末中的药物成分能较快且充分地溶解于水中。
进一步,所述步骤S2具体包括:
先将中药粉末放置于70-100℃水中,再煎煮1-3小时后固液分离,获得中药提取液。
先将粉碎制得的中药粉末加入到70℃以上的热水中,再进行煎煮1-3个小时,能更充分地获取其中的药效成分。
进一步,所述步骤S3具体包括:
将中药提取液进行减压浓缩,得到中药浸膏;
其中,减压浓缩的压强为0.07-0.09MPa。
所谓的减压浓缩,是使用抽真空的方式降低水的沸腾温度使水蒸发。由于浓缩时的温度相对降低,因此减少了中药提取液中热不稳定成分的破坏和损失,更好地保存了中药的药效。
进一步,所述步骤S4具体包括:
将中药浸膏制成颗粒剂后装袋,获得养元补气中药组合物。
将养元补气中药组合物制成颗粒剂,能保持中医辩证施治特色,免除煎药麻烦;其次,制成颗粒剂,使得中药组合物质量可控,能确保疗效,且剂量准确,清洁卫生;再次,颗粒剂携带、服用方便,即冲即服。
本发明提供的养元补气中药组合物及其制备方法,以黄芪、女贞子、五味子、肉苁蓉和枸杞子为原料。其中,黄芪和枸杞子能保证制备的中药组合物具有养元补气的作用;女贞子、五味子和肉苁蓉能赋予组合物添精益肾的功效;五味子和肉苁蓉搭配,能延缓衰老;枸杞子和五味子搭配,能增强人体免疫力;综上,该养元补气中药组合物能为人体补气养元,添精益肾,同时还起到抗衰老,提高人体免疫功能的作用。并且,该养元补气中药组合物对亚健康状态人群具有很好的改善作用,能够促进慢性疾病的康复。
具体实施方式
应该指出,以下详细说明都是例示性的,旨在对本申请提供进一步的说明。除非另有指明,本文使用的所有技术和科学术语具有与本申请所属技术领域的普通技术人员通常理解的相同含义。
需要注意的是,这里所使用的术语仅是为了描述具体实施方式,而非意图限制根据本申请的示例性实施方式。如在这里所使用的,除非上下文另外明确指出,否则单数形式也包括复数形式,此外,还应当理解的是,当在本说明中使用术语“包含”和/或“包括”时,其指明存在特征、步骤、操作、器件、组件和/或它们的组合。
下面将结合实施例对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种养元补气中药组合物,包括以下重量份数的组份,其中1份为10g:
黄芪1份、女贞子1份、五味子1份、肉苁蓉1份和枸杞子1份。
按照如下方法制备养元补气中药组合物:
S1、将黄芪、女贞子、五味子、肉苁蓉和枸杞子混合粉碎,经筛分后获得中药粉末;
S2、将中药粉末放置于水中煎煮后固液分离,获得中药提取液;
S3、将中药提取液进行浓缩,得到中药浸膏;
S4、将中药浸膏进行制剂,获得养元补气中药组合物。
实施例2
一种养元补气中药组合物,包括以下重量份数的组份,其中1份为10g:
黄芪10份、女贞子15份、五味子5份、肉苁蓉20份和枸杞子10份。
按照如下方法制备养元补气中药组合物:
S1、将黄芪、女贞子、五味子、肉苁蓉和枸杞子混合后粉碎,经50目筛筛分后获得中药粉末;
S2、先将中药粉末放置于70℃水中,再煎煮1小时后固液分离,获得中药提取液;
S3、将中药提取液进行减压浓缩,得到中药浸膏;
其中,减压浓缩的压强为0.07MPa;
S4、将中药浸膏制成颗粒剂后装袋,获得。
实施例3
一种养元补气中药组合物,包括以下重量份数的组份,其中1份为10g:
黄芪30份、女贞子35份、五味子30份、肉苁蓉40份和枸杞子30份。
按照如下方法制备养元补气中药组合物:
S1、将黄芪、女贞子、五味子、肉苁蓉和枸杞子混合后粉碎,经75目筛筛分后获得中药粉末;
S2、先将中药粉末放置于85℃水中,再煎煮2小时后固液分离,获得中药提取液;
S3、将中药提取液进行减压浓缩,得到中药浸膏;
其中,减压浓缩的压强为0.08MPa;
S4、将中药浸膏制成颗粒剂后装袋,获得养元补气中药组合物。
实施例4
一种养元补气中药组合物,包括以下重量份数的组份,其中1份为10g:
黄芪50份、女贞子50份、五味子50份、肉苁蓉50份和枸杞子50份。
按照如下方法制备养元补气中药组合物:
S1、将黄芪、女贞子、五味子、肉苁蓉和枸杞子混合后粉碎,经100目筛筛分后获得中药粉末;
S2、先将中药粉末放置于100℃水中,再煎煮3小时后固液分离,获得中药提取液;
S3、将中药提取液进行减压浓缩,得到中药浸膏;
其中,减压浓缩的压强为0.09MPa;
S4、将中药浸膏制成颗粒剂后装袋,获得养元补气中药组合物。
服用养元补气中药组合物的禁忌为:忌食辛辣食品。
采用本发明实施例1-4所制备的养元补气中药组合物进行临床疗效调查,临床案例如下:
病例1、刘某某,男,35岁,经常腰膝酸软,晚上睡眠质量差,经常遗精,性功能下降。2018年4月开始服用本实施例1制备的养元补气中药组合物,中午和晚上各服一次,每次一袋(每袋15克),一个月后,前述症状基本消失。
病例2、周某某,女,48岁,面色苍白、面部有色斑,同时伴有头晕、耳鸣,失眠多梦,潮热盗汗,经中医诊断诊断为肾阴虚。2019年10月开始服用本实施例2制备的养元补气中药组合物,中午和晚上各服一次,每次一袋(每袋15克)。持续服用一个半月后,上述症状全部消失,无反复。
病例3、王某某,男,39岁,常感到神疲乏力,畏寒肢冷,性功能减退、听力下降、须发早白,经中医诊断为肾阳虚。2019年5月开始服用本实施例2制备的养元补气中药组合物,中午和晚上各服一次,每次一袋(每袋15克)。持续服用两个月后,上述症状基本消失,头发返黑。
病例4、朱某某,男,47岁,常潮热盗汗,口干咽燥,有时出现阳强易举、滑精等症状,经中医诊断为肾阴虚。2019年5月开始服用本实施例2制备的养元补气中药组合物,中午和晚上各服一次,每次一袋(每袋15克)。持续服用两个月后,前述症状基本消失。
病例5、张某某,女,38岁,全身机能低下,精神萎靡不振,面色苍白,经中医诊断为肾阴虚。2020年3月开始服用本实施例3制备的养元补气中药组合物,中午和晚上各服一次,每次一袋(每袋15克)。持续服用一个月后,上述症状全部消失。
病例6、邱某某,男,35岁,广州市人,经常有头晕无力,失眠、多梦的症状,并且四肢发寒,易患流感等疾病,身体免疫力较低。2018年1月开始服用本实施例4制备的养元补气中药组合物,中午和晚上各服一次,每次一袋(每袋15克)。持续服用一个月后,前述症状基本消失,性生活得到改善,身体免疫力显著增强,患病次数明显下降。
病例7、杨某某,男,26岁,研究生。学习时注意力不能集中,精神萎靡,且经常遗精。2018年3月开始服用本实施例4制备的养元补气中药组合物,中午和晚上各服一次,每次一袋(每袋15克)。持续服用两个月后,遗精症状消失,精神抖擞,学习效率提高,现仍坚持服用。
最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围。
Claims (7)
1.一种养元补气中药组合物,其特征在于,包括以下重量份数的组份:
黄芪1-50份、女贞子1-50份、五味子1-50份、肉苁蓉1-50份和枸杞子1-50份。
2.根据权利要求1所述养元补气中药组合物,其特征在于,包括以下重量份数的组份:
黄芪10-30份、女贞子15-35份、五味子5-30份、肉苁蓉20-40份和枸杞子10-30份。
3.一种权利要求1-2任意一项所述养元补气中药组合物的制备方法,其特征在于,包括以下步骤:
S1、将黄芪、女贞子、五味子、肉苁蓉和枸杞子混合粉碎,经筛分后获得中药粉末;
S2、将中药粉末放置于水中煎煮后固液分离,获得中药提取液;
S3、将中药提取液进行浓缩,得到中药浸膏;
S4、将中药浸膏进行制剂,获得养元补气中药组合物。
4.根据权利要求3所述养元补气中药组合物的制备方法,其特征在于,所述步骤S1具体包括:
将黄芪、女贞子、五味子、肉苁蓉和枸杞子混合后粉碎,经50-100目筛筛分后获得中药粉末。
5.根据权利要求4所述养元补气中药组合物的制备方法,其特征在于,所述步骤S2具体包括:
先将中药粉末放置于70-100℃水中,再煎煮1-3小时后固液分离,获得中药提取液。
6.根据权利要求5所述养元补气中药组合物的制备方法,其特征在于,所述步骤S3具体包括:
将中药提取液进行减压浓缩,得到中药浸膏;
其中,减压浓缩的压强为0.07-0.09MPa。
7.根据权利要求6所述养元补气中药组合物的制备方法,其特征在于,所述步骤S4具体包括:
将中药浸膏制成颗粒剂后装袋,获得养元补气中药组合物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010604406.6A CN111529598A (zh) | 2020-06-29 | 2020-06-29 | 一种养元补气中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010604406.6A CN111529598A (zh) | 2020-06-29 | 2020-06-29 | 一种养元补气中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111529598A true CN111529598A (zh) | 2020-08-14 |
Family
ID=71976503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010604406.6A Pending CN111529598A (zh) | 2020-06-29 | 2020-06-29 | 一种养元补气中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111529598A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112057522A (zh) * | 2020-09-18 | 2020-12-11 | 江苏康缘药业股份有限公司 | 一种组合物及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1246345A (zh) * | 1998-08-28 | 2000-03-08 | 王欢 | 一种补肾药酒 |
CN100998773A (zh) * | 2007-01-07 | 2007-07-18 | 蔡绪旺 | 一种延年益寿、抗衰老的中药保健制剂 |
SG11201400172YA (en) * | 2011-08-25 | 2014-03-28 | Lillian M Day | Tripartite bioactive composition providing anti-oxidant and anti-inflammatory effects with immune system and stem cell production enhancement |
CN103735875A (zh) * | 2014-01-02 | 2014-04-23 | 许伟 | 补血益气的中药组合物 |
-
2020
- 2020-06-29 CN CN202010604406.6A patent/CN111529598A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1246345A (zh) * | 1998-08-28 | 2000-03-08 | 王欢 | 一种补肾药酒 |
CN100998773A (zh) * | 2007-01-07 | 2007-07-18 | 蔡绪旺 | 一种延年益寿、抗衰老的中药保健制剂 |
SG11201400172YA (en) * | 2011-08-25 | 2014-03-28 | Lillian M Day | Tripartite bioactive composition providing anti-oxidant and anti-inflammatory effects with immune system and stem cell production enhancement |
CN103735875A (zh) * | 2014-01-02 | 2014-04-23 | 许伟 | 补血益气的中药组合物 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112057522A (zh) * | 2020-09-18 | 2020-12-11 | 江苏康缘药业股份有限公司 | 一种组合物及其制备方法 |
WO2022057499A1 (zh) * | 2020-09-18 | 2022-03-24 | 江苏康缘药业股份有限公司 | 一种组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105582333A (zh) | 一种养生补肾黄秋葵酒及其制备方法 | |
CN102078520A (zh) | 一种治疗神经性头痛的中药制剂及其制备方法 | |
CN1245187C (zh) | 一种治疗由脏腑病所致眼病的药物 | |
CN102640829B (zh) | 具有改善心肌缺血功能的茶膏及其制备方法 | |
CN108524814A (zh) | 一种用于降低血糖的中药组合物及其制备方法 | |
CN104305205B (zh) | 一种提高免疫力的菟丝子口服液及其制备方法 | |
CN104352887A (zh) | 一种具有抗肿瘤综合调养膏方及制备工艺 | |
CN111990508A (zh) | 一种益精茶及其制备方法 | |
CN103099833A (zh) | 有助于缓解运动疲劳和延缓衰老的软胶囊及其制备方法 | |
CN104223297B (zh) | 一种延缓衰老的五味子保健口服液及其制备方法 | |
CN111529598A (zh) | 一种养元补气中药组合物及其制备方法 | |
CN104856036B (zh) | 治疗缺铁性贫血的保健药膳及制法 | |
CN110812419A (zh) | 一种固肾强腰的黑参丸和制备方法 | |
CN102784292A (zh) | 一种固本延年的药物制剂及其制备方法 | |
CN105412563A (zh) | 冬虫夏草中药酒 | |
CN111388639B (zh) | 用于缓解绝经综合症的苯乙醇苷和异黄酮提取物及应用 | |
CN113730514A (zh) | 助于提高免疫力的配制酒组合物及其制备方法和使用方法 | |
CN111658720A (zh) | 用于养生的中药组合物、养生丸以及制备方法 | |
CN112402569A (zh) | 一种抗疲劳保健品及其制备方法 | |
CN111317141A (zh) | 一种改善糖尿病的保健食品及其制备方法 | |
CN108853340A (zh) | 一种滋养肝肾的中药及其制备方法 | |
CN103110675A (zh) | 改善营养性贫血软胶囊及其制备方法 | |
US11478523B2 (en) | Oriental medicine composition effective for thyroid hormone level normalization | |
CN108310212A (zh) | 一种用于延缓衰老的药物及其制备方法和应用 | |
CN114712470B (zh) | 一种治疗男士肾亏的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200814 |